• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特定样本基因相互作用的扰动可鉴定胰腺癌亚型。

Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes.

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Dongfengdong Road 651, Guangzhou 510060, China.

Pharm-X Center, Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Dongchuan Road 800, Shanghai 200240, China.

出版信息

Int J Mol Sci. 2022 Apr 26;23(9):4792. doi: 10.3390/ijms23094792.

DOI:10.3390/ijms23094792
PMID:35563183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9099782/
Abstract

Pancreatic cancer is a highly fatal disease and an increasing common cause of cancer mortality. Mounting evidence now indicates that molecular heterogeneity in pancreatic cancer significantly impacts its clinical features. However, the dynamic nature of gene expression pattern makes it difficult to rely solely on gene expression alterations to estimate disease status. By contrast, biological networks tend to be more stable over time under different situations. In this study, we used a gene interaction network from a new point of view to explore the subtypes of pancreatic cancer based on individual-specific edge perturbations calculated by relative gene expression value. Our study shows that pancreatic cancer patients from the TCGA database could be separated into four subtypes based on gene interaction perturbations at the individual level. The new network-based subtypes of pancreatic cancer exhibited substantial heterogeneity in many aspects, including prognosis, phenotypic traits, genetic mutations, the abundance of infiltrating immune cell, and predictive therapeutic efficacy (chemosensitivity and immunotherapy efficacy). The new network-based subtypes were closely related to previous reported molecular subtypes of pancreatic cancer. This work helps us to better understand the heterogeneity and mechanisms of pancreatic cancer from a network perspective.

摘要

胰腺癌是一种高度致命的疾病,也是癌症死亡率不断上升的常见原因。越来越多的证据表明,胰腺癌中的分子异质性显著影响其临床特征。然而,基因表达模式的动态性质使得仅依赖基因表达改变来估计疾病状态变得困难。相比之下,生物网络在不同情况下往往更稳定。在这项研究中,我们从一个新的角度使用基因相互作用网络,基于通过相对基因表达值计算的个体特异性边缘扰动,来探索基于个体的胰腺癌亚型。我们的研究表明,基于个体水平基因相互作用扰动,来自 TCGA 数据库的胰腺癌患者可以分为四个亚型。基于基因相互作用的胰腺癌新型网络亚型在许多方面表现出显著的异质性,包括预后、表型特征、遗传突变、浸润免疫细胞的丰度以及预测治疗效果(化疗敏感性和免疫治疗效果)。新的基于网络的亚型与先前报道的胰腺癌分子亚型密切相关。这项工作有助于我们从网络角度更好地理解胰腺癌的异质性和机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/6b0050fe51f8/ijms-23-04792-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/520d27994ed4/ijms-23-04792-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/daf6c91f29e6/ijms-23-04792-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/c4842be5190d/ijms-23-04792-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/b60dee1841b5/ijms-23-04792-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/f9951122303c/ijms-23-04792-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/19f59690ad0e/ijms-23-04792-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/a8915e2ea1ba/ijms-23-04792-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/cac41107682e/ijms-23-04792-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/6b0050fe51f8/ijms-23-04792-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/520d27994ed4/ijms-23-04792-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/daf6c91f29e6/ijms-23-04792-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/c4842be5190d/ijms-23-04792-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/b60dee1841b5/ijms-23-04792-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/f9951122303c/ijms-23-04792-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/19f59690ad0e/ijms-23-04792-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/a8915e2ea1ba/ijms-23-04792-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/cac41107682e/ijms-23-04792-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/9099782/6b0050fe51f8/ijms-23-04792-g009.jpg

相似文献

1
Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes.特定样本基因相互作用的扰动可鉴定胰腺癌亚型。
Int J Mol Sci. 2022 Apr 26;23(9):4792. doi: 10.3390/ijms23094792.
2
Sample-specific perturbation of gene interactions identifies breast cancer subtypes.特定样本的基因相互作用扰动可鉴定乳腺癌亚型。
Brief Bioinform. 2021 Jul 20;22(4). doi: 10.1093/bib/bbaa268.
3
SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.SCNrank:基于网络的排序的谱聚类揭示潜在的药物靶点及其在胰腺导管腺癌中的应用。
BMC Med Genomics. 2020 Apr 3;13(Suppl 5):50. doi: 10.1186/s12920-020-0681-6.
4
Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.鉴定与细胞外囊泡相关的基因特征可预测胰腺癌的临床预后。
Biosci Rep. 2020 Dec 23;40(12). doi: 10.1042/BSR20201087.
5
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.对 1200 例胰腺导管腺癌的基因表达谱分析揭示了新的亚型。
BMC Cancer. 2018 May 29;18(1):603. doi: 10.1186/s12885-018-4546-8.
6
Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.全面分析 m6A RNA 甲基化调控因子与免疫微环境以辅助胰腺癌免疫治疗
Front Immunol. 2021 Nov 5;12:769425. doi: 10.3389/fimmu.2021.769425. eCollection 2021.
7
A Network-Based Approach for Identification of Subtype-Specific Master Regulators in Pancreatic Ductal Adenocarcinoma.基于网络的方法鉴定胰腺导管腺癌亚型特异性主调控因子
Genes (Basel). 2020 Feb 1;11(2):155. doi: 10.3390/genes11020155.
8
Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.鉴定胰腺癌中的免疫细胞浸润图谱以辅助免疫治疗。
Future Oncol. 2021 Nov;17(31):4131-4143. doi: 10.2217/fon-2021-0495. Epub 2021 Aug 4.
9
Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.整合生物信息学分析鉴定 COL11A1 为胰腺腺癌中与免疫浸润相关的预后标志物。
Int Immunopharmacol. 2021 Jan;90:106982. doi: 10.1016/j.intimp.2020.106982. Epub 2020 Oct 29.
10
New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.从单细胞 lncRNA 表达分析中获得胶质母细胞瘤精准治疗的新见解。
J Cancer Res Clin Oncol. 2021 Jul;147(7):1881-1895. doi: 10.1007/s00432-021-03584-9. Epub 2021 Mar 11.

引用本文的文献

1
Unveiling genetic susceptibility in esophageal squamous cell carcinoma and revolutionizing pancreatic cancer diagnosis through imaging.揭示食管鳞状细胞癌的遗传易感性并通过成像彻底改变胰腺癌诊断。
World J Gastrointest Oncol. 2025 Jun 15;17(6):102544. doi: 10.4251/wjgo.v17.i6.102544.
2
Molecular mechanism of RBM14-mediated promotion of proliferation, migration, and invasion in osteosarcoma.RBM14介导骨肉瘤增殖、迁移和侵袭的分子机制
Transl Cancer Res. 2024 May 31;13(5):2122-2140. doi: 10.21037/tcr-23-2070. Epub 2024 May 28.
3
Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response.

本文引用的文献

1
Pevonedistat Suppresses Pancreatic Cancer Growth Inactivation of the Neddylation Pathway.pevonedistat通过使Neddylation途径失活来抑制胰腺癌生长。
Front Oncol. 2022 Jan 26;12:822039. doi: 10.3389/fonc.2022.822039. eCollection 2022.
2
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials.不可切除肝细胞癌的双重检查点阻断:临床试验中的新机遇。
Expert Opin Investig Drugs. 2022 Apr;31(4):425-435. doi: 10.1080/13543784.2022.2042253. Epub 2022 Feb 22.
3
Mechanisms of immune activation and regulation: lessons from melanoma.
利用胰腺癌中的肿瘤微环境浸润来鉴定与预后和免疫治疗反应相关的基因特征。
Cancers (Basel). 2023 Feb 24;15(5):1442. doi: 10.3390/cancers15051442.
4
Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma.构建并综合分析与胰腺腺癌 pyroptosis 分子亚型相关的新型预后标志物。
Front Immunol. 2023 Feb 3;14:1111494. doi: 10.3389/fimmu.2023.1111494. eCollection 2023.
免疫激活和调节的机制:黑色素瘤的启示。
Nat Rev Cancer. 2022 Apr;22(4):195-207. doi: 10.1038/s41568-022-00442-9. Epub 2022 Feb 1.
4
Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer.胰腺肿瘤微环境中巨噬细胞与中性粒细胞的相互作用推动胰腺癌的发病机制。
Cancers (Basel). 2021 Dec 31;14(1):194. doi: 10.3390/cancers14010194.
5
Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer.可切除非小细胞肺癌的术前和术后全身治疗。
J Clin Oncol. 2022 Feb 20;40(6):546-555. doi: 10.1200/JCO.21.01589. Epub 2022 Jan 5.
6
Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.同时抑制 IGF1R 和 ERK 可提高胰腺癌对自噬抑制剂的敏感性。
Cancer Res. 2022 Feb 15;82(4):586-598. doi: 10.1158/0008-5472.CAN-21-1443.
7
CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients.CpG岛甲基化表型调节肿瘤微环境的免疫反应并影响胰腺癌患者的预后。
J Oncol. 2021 Nov 28;2021:2715694. doi: 10.1155/2021/2715694. eCollection 2021.
8
Elevated Neddylation Pathway Promotes Th2 Cells Infiltration by Transactivating STAT5A in Hepatocellular Carcinoma.Neddylation途径的激活通过反式激活信号转导和转录激活因子5A促进肝癌中Th2细胞浸润。
Front Oncol. 2021 Nov 5;11:709170. doi: 10.3389/fonc.2021.709170. eCollection 2021.
9
A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma.一种新的与干性相关的预测胰腺导管腺癌预后的模型。
Biomed Res Int. 2021 Oct 11;2021:6669570. doi: 10.1155/2021/6669570. eCollection 2021.
10
ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cells.醛缩酶A通过ATM-PLK1途径抑制胰腺癌细胞中由DNA损伤诱导的细胞周期停滞。
Cancer Cell Int. 2021 Sep 26;21(1):514. doi: 10.1186/s12935-021-02210-5.